GLP-1 receptor agonists have changed obesity medicine more than any intervention in decades. They have also created a market full of unsupervised prescribing, where patients receive a vial and a syringe with no labs, no nutrition plan, no strength training guidance and no exit strategy. Medical weight management at Omnia Wellness Center in Encino is built around everything that happens alongside the medication, because that is what determines whether the result lasts.
How These Medications Work
Glucagon-like peptide-1 is an incretin hormone released by the gut after eating. It stimulates glucose-dependent insulin secretion, suppresses glucagon, slows gastric emptying, and acts on hypothalamic centers that regulate appetite. Semaglutide is a GLP-1 receptor agonist. Tirzepatide is a dual agonist, acting on both GLP-1 and GIP receptors, which in head-to-head trials produces greater average weight reduction.
Patients consistently describe the same subjective experience: the constant background negotiation about food quiets down. That phenomenon — often called reduction of 'food noise' — is not willpower arriving late. It is the correction of a dysregulated appetite signaling system, and framing it that way removes a great deal of unwarranted shame from the conversation.
What Medical Supervision Adds
- Baseline labs: comprehensive metabolic panel, HbA1c, fasting insulin, lipids, thyroid function, liver enzymes and kidney function.
- Screening for contraindications: personal or family history of medullary thyroid carcinoma, MEN2 syndrome, history of pancreatitis, active gallbladder disease, pregnancy or planned pregnancy.
- Structured dose titration that prioritizes tolerability over speed — most side effects are dose-escalation artifacts, not inevitabilities.
- Body composition tracking, so that we know whether you are losing fat or muscle.
- Protein and resistance-training programming to protect lean mass.
- Regular follow-up with dose adjustment, and a plan for what happens at goal weight.
Managing Side Effects
Nausea, constipation, reflux and early satiety are common in the first weeks and during each dose increase. Most are manageable: smaller meals, reduced fat content at meals, adequate fluid, fiber and magnesium for constipation, and slowing titration when needed. There is no clinical prize for reaching the maximum dose quickly. The correct dose is the lowest one producing steady progress at an acceptable quality of life.
Protecting Muscle — The Part Most Programs Skip
In rapid weight loss, a substantial fraction of the loss can come from lean tissue. That is metabolically counterproductive: muscle is the primary site of glucose disposal and a major determinant of resting metabolic rate, so losing it makes maintenance harder and rebound more likely. Every patient in our program gets a protein target — generally 1.2 to 1.6 grams per kilogram of goal body weight — and a resistance training recommendation of two to four sessions weekly. We track body composition rather than scale weight alone, and we will slow the taper if lean mass is falling.
Facial Volume Loss And What To Do About It
Rapid weight loss depletes the deep and superficial facial fat compartments, producing the hollowed, gaunt appearance widely discussed as 'Ozempic face.' It is simply fat loss in a place people did not want it. Because we are also an aesthetics practice, we can address it directly: biostimulators to rebuild collagen and diffuse volume, hyaluronic acid filler for targeted structural restoration, and Fotona treatments for the skin laxity that accompanies significant loss. Coordinating aesthetic and metabolic care under one roof is a genuine advantage for these patients.
The medication makes eating less feel possible. What you do with that window — protein, training, sleep, habits — determines whether the result survives stopping it.
Peptides And Adjunct Therapies
Our apothecary includes evidence-based peptide consultations and vitamin injections that support the program: B12 and MICC injections for energy and metabolic support, and targeted nutrient repletion, since reduced food volume genuinely reduces micronutrient intake. IV therapy can be useful for patients struggling with hydration during titration. These are adjuncts to the core program, not substitutes for it.
Maintenance And Exit Planning
Obesity is a chronic condition, and discontinuation without a plan is typically followed by regain — that is physiology, not personal failure. Some patients remain on a reduced maintenance dose long term. Others taper gradually while relying on established habits, strong lean mass and continued monitoring. We discuss this at the first visit rather than the last, because a program with no defined endpoint is not a medical plan.
Omnia Wellness Center offers medical weight management to patients throughout Encino, Sherman Oaks, Tarzana, Van Nuys, Woodland Hills and the greater San Fernando Valley, with physician-directed oversight, real laboratory monitoring, and financing available through Cherry, Afterpay and CareCredit.
Book a Consultation in Encino
Omnia Wellness Center is located in the heart of Encino, minutes from Sherman Oaks, Tarzana, Studio City, Woodland Hills, Van Nuys, Calabasas, and Beverly Hills. Every treatment plan begins with a private consultation, a full assessment, and an honest conversation about what will — and will not — help you reach your goals. Call or text (818) 853-1351, or book online, and our clinical team will build a plan around your anatomy, your timeline, and your budget.
